Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin family domain containing 1 (UBFD1) is a protein-coding gene encoding a ubiquitin domain-containing protein, sometimes known as a ubiquitin-binding protein homolog[3][12]. UBFD1 may play a role as a regulator of NF-kappa-B, a transcription factor central to inflammation and immune regulation[1][12]. It is annotated as having RNA binding and cadherin binding activity[11][3]. UBFD1 has recently been identified as an independent risk factor and prognostic biomarker in estrogen receptor-positive breast cancer, with higher expression correlating to poorer prognosis; its functional associations include hormone activity and inflammation[2]. Although UBFD1 interacts in cellular networks involving components of the 26S proteasome, it is not currently linked to direct drug targeting or to specific drug mechanisms[1][2][3][12]. There are no known safety concerns from targeting UBFD1, and its classification is as an "Other" molecular family protein rather than a classic enzyme, receptor, or ion channel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin family domain containing 1 (UBFD1).